BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 9689188)

  • 1. Estrogen replacement therapy and urinary tract infections in postmenopausal women aged 45-89.
    Oliveria SA; Klein RA; Reed JI; Cirillo PA; Christos PJ; Walker AM
    Menopause; 1998; 5(1):4-8. PubMed ID: 9689188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for urinary tract infections in postmenopausal women.
    Hu KK; Boyko EJ; Scholes D; Normand E; Chen CL; Grafton J; Fihn SD
    Arch Intern Med; 2004 May; 164(9):989-93. PubMed ID: 15136308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone replacement therapy and risk for coronary heart disease. Data from the CORA-study--a case-control study on women with incident coronary heart disease.
    Windler E; Zyriax BC; Eidenmüller B; Boeing H
    Maturitas; 2007 Jul; 57(3):239-46. PubMed ID: 17292571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen replacement therapy and mortality among older women. The study of osteoporotic fractures.
    Cauley JA; Seeley DG; Browner WS; Ensrud K; Kuller LH; Lipschutz RC; Hulley SB
    Arch Intern Med; 1997 Oct; 157(19):2181-7. PubMed ID: 9342994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen replacement therapy and ovarian cancer.
    Folsom AR; Anderson JP; Ross JA
    Epidemiology; 2004 Jan; 15(1):100-4. PubMed ID: 14712153
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of estrogen replacement therapy use in northern Italy.
    Parazzini F; La Vecchia C; Negri E; Bianchi C; Fedele L
    Rev Epidemiol Sante Publique; 1993; 41(1):53-8. PubMed ID: 8465065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuation of postmenopausal hormone replacement therapy in a large health maintenance organization: transdermal matrix patch versus oral estrogen therapy.
    Ettinger B; Pressman A
    Am J Manag Care; 1999 Jun; 5(6):779-85. PubMed ID: 10538456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for recurrent urinary tract infection in young women.
    Scholes D; Hooton TM; Roberts PL; Stapleton AE; Gupta K; Stamm WE
    J Infect Dis; 2000 Oct; 182(4):1177-82. PubMed ID: 10979915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen replacement therapy and risk of Alzheimer disease.
    Paganini-Hill A; Henderson VW
    Arch Intern Med; 1996 Oct; 156(19):2213-7. PubMed ID: 8885820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen replacement therapy and retinal vascular caliber.
    Wong TY; Knudtson MD; Klein BE; Klein R; Hubbard LD
    Ophthalmology; 2005 Apr; 112(4):553-8. PubMed ID: 15808243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study.
    Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT
    Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
    Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
    J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen therapy in older patients with recurrent urinary tract infections: a review.
    Rozenberg S; Pastijn A; Gevers R; Murillo D
    Int J Fertil Womens Med; 2004; 49(2):71-4. PubMed ID: 15188831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of urinary tract infection after menopause: a prospective study.
    Jackson SL; Boyko EJ; Scholes D; Abraham L; Gupta K; Fihn SD
    Am J Med; 2004 Dec; 117(12):903-11. PubMed ID: 15629728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent urinary tract infections in postmenopausal women.
    Raz R; Gennesin Y; Wasser J; Stoler Z; Rosenfeld S; Rottensterich E; Stamm WE
    Clin Infect Dis; 2000 Jan; 30(1):152-6. PubMed ID: 10619744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy use and variations in the risk of breast cancer.
    Opatrny L; Dell'Aniello S; Assouline S; Suissa S
    BJOG; 2008 Jan; 115(2):169-75; discussion 175. PubMed ID: 18081598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and urodynamic parameters associated with history of urinary tract infections in women.
    Athanasiou S; Anstaklis A; Betsi GI; Sotiropoulou M; Falagas ME
    Acta Obstet Gynecol Scand; 2007; 86(9):1130-5. PubMed ID: 17712657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.
    Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Rosendaal FR; Psaty BM
    Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2807-12. PubMed ID: 16973976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The benefits of estrogen replacement therapy on oral health. The Leisure World cohort.
    Paganini-Hill A
    Arch Intern Med; 1995 Nov; 155(21):2325-9. PubMed ID: 7487257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of urinary incontinence in a prospective cohort of postmenopausal women.
    Jackson SL; Scholes D; Boyko EJ; Abraham L; Fihn SD
    Obstet Gynecol; 2006 Oct; 108(4):855-62. PubMed ID: 17012446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.